COMP <GO>
DAR vs CPB // REVENUE GROWTH (YOY)
Darling Ingredients Inc. (NYSE) VS. The Campbell's Company (NASDAQ) • 15-METRIC TALLY: DAR 4
— CPB 9
▲ REVENUE GROWTH (YOY) LEADER: DAR
LAST: $55.15 (-0.56%) • MKT CAP: $8.70B
revenue-growth
7.40%
LAST: $21.00 (+1.99%) • MKT CAP: $6.26B
revenue-growth
6.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DAR VS. CPB)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DAR | CPB | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.00% | 30.40% | -6.40 | CPB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.10% | 10.80% | -7.70 | CPB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 7.0x | +11.30 | CPB | /valuation <GO> |
| Free Cash Flow Yield | 7.80% | 11.26% | -3.46 | CPB | /fcf-yield <GO> |
| Operating Margin | 4.50% | 11.00% | -6.50 | CPB | /operating-margins <GO> |
| Net Profit Margin | 1.00% | 5.90% | -4.90 | CPB | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 7.40% | 6.40% | +1.00 | DAR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 7.33% | -7.33 | CPB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.25 | 1.68 | +0.57 | DAR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.9 | 56.1 | -21.20 | CPB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.99 | +0.02 | DAR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 128.9x | 9.7x | +119.20 | CPB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.70B | $6.26B | $2.44B | DAR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DAR REV | CPB REV | DAR GROSS % | CPB GROSS % | DAR FCF | CPB FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.14B | $10.25B | 24.0% | 30.4% | $679.2M | $705.0M |
| FY 2024 | $5.72B | $9.64B | 22.4% | 30.8% | $506.8M | $668.0M |
| FY 2023 | $6.79B | $9.36B | — | — | $593.8M | $721.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DAR // BETA 1.01
CPB // BETA 0.99